Martha Goldberg Aronson's most recent trade in Merit Medical Systems, Inc. was a trade of 28,198 Common Stock, No Par Value done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merit Medical Systems Inc | Martha Goldberg Aronson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 28,198 | 47,792 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems Inc | Martha Goldberg Aronson | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 19,594 | 19,594 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems Inc | Martha Goldberg Aronson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 19,594 | 19,594 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Conmed Corp | Martha Goldberg Aronson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 8,061 | 8,061 | - | - | Options To Purchase Common Stock | |
| Conmed Corp | Martha Goldberg Aronson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 668 | 668 | - | - | RSUs (Restricted Stock Units) | |
| Conmed Corp | Martha Goldberg Aronson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 479 | 12,391 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp | Martha Goldberg Aronson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 479 | 0 | - | - | RSUs (Restricted Stock Units) | |
| Conmed Corp | Martha Goldberg Aronson | Director | 31 May 2024 | 5,503 | 5,503 | - | - | Options To Purchase Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 31 May 2024 | 479 | 479 | - | - | Rsus (restricted Stock Units) | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 31 May 2024 | 302 | 11,912 (0%) | 0% | 0 | Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 31 May 2024 | 302 | 0 | - | - | Rsus (restricted Stock Units) | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 06 May 2024 | 2,000 | 2,000 (0%) | 0% | 71.0 | 141,960 | Common Stock | |
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2023 | 2,826 | 2,826 | - | - | Options To Purchase Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2023 | 335 | 0 | - | - | Rsus (restricted Stock Units) | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2023 | 335 | 11,610 (0%) | 0% | 0 | Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2023 | 302 | 302 | - | - | Rsus (restricted Stock Units) | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2022 | 3,453 | 3,453 | - | - | Options To Purchase Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2022 | 812 | 11,275 (0%) | 0% | 0 | Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2022 | 812 | 0 | - | - | Rsus (restricted Stock Units) | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2022 | 335 | 335 | - | - | Rsus (restricted Stock Units) | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2021 | 1,521 | 10,463 (0%) | 0% | 0 | Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2021 | 1,521 | 0 | - | - | Rsus (restricted Stock Units) | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2021 | 865 | 865 | - | - | Options To Purchase Common Stock | ||
| Conmed Corp | Martha Goldberg Aronson | Director | 01 Jun 2021 | 812 | 812 | - | - | Rsus (restricted Stock Units) |